Sol J. Barer
CIK: 0001247015
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct21.7K shares- - May 28, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
10.9K shares- - Jun 6, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct17.2K shares- - Jun 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
21.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 21,739 | - | $0 | Direct |
| May 28, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 10,863 | - | - | Direct |
| Jun 6, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 17,158 | - | - | Direct |
| Jun 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 21,739 | - | - | Direct |
1-4 of 4 transactions
About BARER SOL J
BARER SOL J (SEC CIK 0001247015) files insider reports with the SEC as Director of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
Signal8 holds 3 ownership filings by BARER SOL J, all Form 4s, filed between Jun 9, 2025 and Jun 8, 2026. Those filings report 4 transactions, from Jun 5, 2025 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BARER SOL J's filings is in TEL AVIV.
Recent filings by BARER SOL J
Other insiders filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
- Bergwerk Dov, Interim Cheif Legal Officer
- Savage Brian, Interim Chief Legal Officer
- MIGNONE ROBERTO, Director
- Weiss Amir, Chief Accounting Officer
- Satchi-Fainaro Ronit, Director
- Lippman Evan, EVP, Business Development